Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Introduction to PT-141 (Bremelanotide) Research PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide and melanocortin receptor agonist with primary affinity for the MC4R subtype
Do I understand this is a research-stage peptide, not an FDA-approved drug
Funded in 1978, this grant (AM 24039) allowed Mojsov to continue in the Merrifield lab as a Research Associate, and to hire a technician
The number of injections and length of time is independent of each individuals needs
Mercury-induced excitotoxicity in autism spectrum disorder: disruption of glutamatergic homeostasis and the therapeutic role of the seleniumglutathione axis
Some peptides may help regulate hormones, contributing to better overall health and wellness for women
US$ 29.04
US$ 28.02
US$ 21.40
US$ 25.95
